1
Guangzhou Medical Research Institute of Infectious Diseases, Department of Pharmacy, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China
2
Karolinska Institute United Medical Inflammation Center, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
3
Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czechia
4
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
5
Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China
6
Department of Endocrinology, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China
7
Department of Environmental and Biosciences, School of Business, Innovation and Sustainability, Halmstad University, Halmstad, Sweden
8
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion, Crete, Greece
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Kutty Selva Nandakumar, nandakumar@smu.edu.cn; Michail Kotsyfakis, kotsyfakis@paru.cas.cz
†These authors have contributed equally to this work
Copyright © 2025 Wu, Jmel, Chai, Tian, Xu, Hui, Nandakumar and Kotsyfakis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.